Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is associated with co-morbid psychiatric symptoms (disruptive behavior, anxiety, mood disorders, and psychosis) often requiring psychotropic medications. In this clinical case series of 35 patients with PWS, pharmacogenetic testing was obtained to determine allele frequen...
Main Authors: | Janice Forster, Jessica Duis, Merlin G. Butler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/2/152 |
Similar Items
-
Pharmacodynamic Gene Testing in Prader-Willi Syndrome
by: Janice Forster, et al.
Published: (2020-11-01) -
Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome
by: Chong Kun Cheon
Published: (2016-09-01) -
Prader Willi Syndrome: A Family's Experience
by: Emma Walker
Published: (2006-01-01) -
Prader-Willi Syndrome
by: J Gordon Millichap
Published: (1991-12-01) -
Behavioural characterization of a mouse model for Prader-Willi syndrome
by: Relkovic, Dinko
Published: (2010)